About the Study

Hepatitis B Infection: A clinical study of tenofovir alafenamide in children and adolescents with long term hepatitis B infection

This study is enrolling participants who: - Are children who are 2 to less than 6 years of age - Have chronic (long term) hepatitis B virus infection Chronic Hepatitis B is a viral liver infection. The purpose of this study is to see if Tenofovir Alafenamide is safe, tolerable, and effective in treating children and adolescents with hepatitis B virus infection.

Interested in learning more?

Full Study Name: Gilead Hepatitis B TAF Study